R777-E235 Hs.RASAL2 Citations (2)
Originally described in: Esposito labUnpublished
Articles Citing R777-E235 Hs.RASAL2
| Articles |
|---|
| RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer. Koh SB, Ross K, Isakoff SJ, Melkonjan N, He L, Matissek KJ, Schultz A, Mayer EL, Traina TA, Carey LA, Rugo HS, Liu MC, Stearns V, Langenbucher A, Saladi SV, Ramaswamy S, Lawrence MS, Ellisen LW. Clin Cancer Res. 2021 Sep 1;27(17):4883-4897. doi: 10.1158/1078-0432.CCR-21-0714. Epub 2021 Jun 24. PubMed |
| CREB1-BCL2 drives mitochondrial resilience in RAS GAP-dependent breast cancer chemoresistance. Man KF, Darweesh O, Hong J, Thompson A, O'Connor C, Bonaldo C, Melkonyan MN, Sun M, Patel R, Ellisen LW, Robinson T, Song D, Koh SB. Oncogene. 2025 May;44(16):1093-1105. doi: 10.1038/s41388-025-03284-5. Epub 2025 Jan 31. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.